ESRRA and cancer: Subsequent immunohistochemical analyses, mRNA quantification and gene expression profiles in several solid tumors (breast, cervix, colon, endometrium, ovary and prostate) are in agreement with Ariazi et al. and relate ERRα overexpression to cancer aggressiveness, increased risk of recurrence and lower survival [9,76,81,82,83,84,85].